Low good cholesterol A study of nearly 7,000 people led by a researcher at Indiana University analyzed the relationship between HDL, or good cholesterol, and
major coronary events.
Each two
major coronary events have shown to be prevented by prophylactic aspirin at the cost of one major extracranial bleed.
Not exact matches
The Xarelto partnership is seeking additional approved uses, with trials underway in patients with acute
coronary syndrome, and for reduction of
major adverse cardiovascular
events in patients with heart failure or peripheral artery disease.
That analysis of published large randomized trials calculated that each 77 - point drop in LDL cholesterol (a 2 millimole per liter drop) reduced the risk of a
major cardiovascular
event — heart attack, stroke or the need for a
coronary - clearing procedure — by 45 percent.
During the nearly month - long follow - up period, there were no differences between the two groups in the percentages of patients that had a stent placed to open an artery, underwent
coronary artery bypass surgery, returned to the emergency room or experienced a
major cardiac
event, such as heart attack.
«Type 2 diabetes accompanied by an acute
coronary syndrome needs much more attention, especially in order to prevent yet another
major cardiac
event,» says Principal Investigator Dr. William B. White, a professor in the Pat and Jim Calhoun Cardiology Center at UConn Health.
Patients with acute
coronary syndrome undergoing angioplasty who received the anticoagulant drug bivalirudin did not show significant improvements in either of two co-primary endpoints — a composite of rate of death, heart attack or stroke at 30 days, or a composite of those
events plus
major bleeding — as compared to patients receiving standard anticoagulation therapy, according to a study presented at the American College of Cardiology's 64th Annual Scientific Session.
(HealthDay)-- Elevated fibroblast growth factor 23 (FGF - 23) is associated with increased risk of recurrent
major cardiovascular (CV)
events in patients after an acute
coronary syndrome (ACS), according to a study published...
Elevated fibroblast growth factor 23 (FGF - 23) is associated with increased risk of recurrent
major cardiovascular (CV)
events in patients after an acute
coronary syndrome (ACS), according to a study published online April 18 in JAMA Cardiology.
It should be noted that the only hospitals equipped to handle emergencies or
major health problems — such as
coronary events — are located in Belize City.
Does anhedonia and / or depressed mood predict recurrent
major adverse cardiac
events (MACEs) in people with acute
coronary syndromes (ACS)?
Myeloperoxidase and High - Sensitivity C - Reactive Protein for Predicting
Major Adverse Cardiovascular
Events in Patients with
Coronary Heart Disease